212 related articles for article (PubMed ID: 22179404)
1. Blockade of NKG2D synergized with CTLA4-Ig in promoting long-term graft survival in murine models of cardiac transplantation.
Li J; Zhu H; Wang S; Ye P; Liu C; Wu J; Xia J
Transplantation; 2012 Feb; 93(4):356-63. PubMed ID: 22179404
[TBL] [Abstract][Full Text] [Related]
2. NKG2D blockade attenuated cardiac allograft vasculopathy in a mouse model of cardiac transplantation.
Chen H; Xia J; Zhang L; Jin X; Yang M; Li J; Zhao Y
Clin Exp Immunol; 2013 Sep; 173(3):544-52. PubMed ID: 23638995
[TBL] [Abstract][Full Text] [Related]
3. NKG2D blockade significantly attenuates ischemia-reperfusion injury in a cardiac transplantation model.
Shen B; Li J; Yang B
Transplant Proc; 2013; 45(6):2513-6. PubMed ID: 23953572
[TBL] [Abstract][Full Text] [Related]
4. γδ T cell receptor deficiency attenuated cardiac allograft vasculopathy and promoted regulatory T cell expansion.
Zhu H; Li J; Wang S; Liu K; Wang L; Huang L
Scand J Immunol; 2013 Jul; 78(1):44-9. PubMed ID: 23659436
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28.
Lin H; Rathmell JC; Gray GS; Thompson CB; Leiden JM; Alegre ML
J Exp Med; 1998 Jul; 188(1):199-204. PubMed ID: 9653096
[TBL] [Abstract][Full Text] [Related]
6. Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts.
Mandelbrot DA; Furukawa Y; McAdam AJ; Alexander SI; Libby P; Mitchell RN; Sharpe AH
J Immunol; 1999 Oct; 163(7):3753-7. PubMed ID: 10490971
[TBL] [Abstract][Full Text] [Related]
7. Transplantation tolerance induced by CTLA4-Ig.
Pearson TC; Alexander DZ; Winn KJ; Linsley PS; Lowry RP; Larsen CP
Transplantation; 1994 Jun; 57(12):1701-6. PubMed ID: 8016872
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-17 accelerates allograft rejection by suppressing regulatory T cell expansion.
Itoh S; Kimura N; Axtell RC; Velotta JB; Gong Y; Wang X; Kajiwara N; Nambu A; Shimura E; Adachi H; Iwakura Y; Saito H; Okumura K; Sudo K; Steinman L; Robbins RC; Nakae S; Fischbein MP
Circulation; 2011 Sep; 124(11 Suppl):S187-96. PubMed ID: 21911812
[TBL] [Abstract][Full Text] [Related]
9. CTLA4-Ig plus bone marrow induces long-term allograft survival and donor specific unresponsiveness in the murine model. Evidence for hematopoietic chimerism.
Pearson TC; Alexander DZ; Hendrix R; Elwood ET; Linsley PS; Winn KJ; Larsen CP
Transplantation; 1996 Apr; 61(7):997-1004. PubMed ID: 8623206
[TBL] [Abstract][Full Text] [Related]
10. Induction of immunologic tolerance to cardiac allograft by simultaneous blockade of inducible co-stimulator and cytotoxic T-lymphocyte antigen 4 pathway.
Kosuge H; Suzuki J; Gotoh R; Koga N; Ito H; Isobe M; Inobe M; Uede T
Transplantation; 2003 Apr; 75(8):1374-9. PubMed ID: 12717233
[TBL] [Abstract][Full Text] [Related]
11. Potential role of γδ T cell-derived IL-17 in acute cardiac allograft rejection.
Kimura N; Nakae S; Itoh S; Merk DR; Wang X; Gong Y; Okamura H; Chang PA; Adachi H; Robbins RC; Fischbein MP
Ann Thorac Surg; 2012 Aug; 94(2):542-8. PubMed ID: 22560321
[TBL] [Abstract][Full Text] [Related]
12. Administration of anti-interleukin-6 monoclonal antibody prolongs cardiac allograft survival.
Lei J; He F; Wu M; Zheng X; Chen X; Chen Z
Transpl Int; 2010 Dec; 23(12):1271-81. PubMed ID: 20646257
[TBL] [Abstract][Full Text] [Related]
13. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
Cai Y; Tang XD; Zhou PJ
Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
[TBL] [Abstract][Full Text] [Related]
14. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance.
Zhou P; Szot GL; Guo Z; Kim O; He G; Wang J; Grusby MJ; Newell KA; Thistlethwaite JR; Bluestone JA; Alegre ML
J Immunol; 2000 Nov; 165(10):5580-7. PubMed ID: 11067913
[TBL] [Abstract][Full Text] [Related]
15. Tumor-infiltrating IL-17-producing gammadelta T cells support the progression of tumor by promoting angiogenesis.
Wakita D; Sumida K; Iwakura Y; Nishikawa H; Ohkuri T; Chamoto K; Kitamura H; Nishimura T
Eur J Immunol; 2010 Jul; 40(7):1927-37. PubMed ID: 20397212
[TBL] [Abstract][Full Text] [Related]
16. Perturbation of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival.
Grazia TJ; Gill RG; Gelhaus HC; Doan AN; Sleater ML; Pietra BA
J Heart Lung Transplant; 2005 Sep; 24(9):1410-4. PubMed ID: 16143264
[TBL] [Abstract][Full Text] [Related]
17. Deletion of the activating NK cell receptor NKG2D accelerates rejection of cardiac allografts.
Fabritius C; Ritschl PV; Resch T; Roth M; Ebner S; Günther J; Mellitzer V; Nguyen AV; Pratschke J; Sauter M; Klingel K; Kotsch K
Am J Transplant; 2017 Dec; 17(12):3199-3209. PubMed ID: 28805342
[TBL] [Abstract][Full Text] [Related]
18. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K
J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564
[TBL] [Abstract][Full Text] [Related]
19. Role of the CTLA4 pathway in hyporesponsiveness induced by intratracheal delivery of alloantigen.
Shirasugi N; Akiyama Y; Aramaki O; Shibutani S; Matsumoto K; Bashuda H; Yagita H; Okumura K; Ikeda Y; Niimi M
Transplantation; 2003 May; 75(10):1636-9. PubMed ID: 12777848
[TBL] [Abstract][Full Text] [Related]
20. Blockade of LIGHT/HVEM and B7/CD28 signaling facilitates long-term islet graft survival with development of allospecific tolerance.
Fan K; Wang H; Wei H; Zhou Q; Kou G; Hou S; Qian W; Dai J; Li B; Zhang Y; Zhu T; Guo Y
Transplantation; 2007 Sep; 84(6):746-54. PubMed ID: 17893608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
